Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
Study efficacy of everolimus on course of uveitis:
- obtain quiescence of inflammation after start of treatment
- duration to obtain quiescence of inflammation
- number of patients with quiescence of inflammation